This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schaumann, R.
Right arrow Articles by Rodloff, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schaumann, R.
Right arrow Articles by Rodloff, A. C.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, November 1999, p. 2783-2786, Vol. 43, No. 11
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

In Vitro Activities of Gatifloxacin, Two Other Quinolones, and Five Nonquinolone Antimicrobials against Obligately Anaerobic Bacteria

Reiner Schaumann,* Grit Ackermann, Baerbel Pless, Marina C. Claros, and Arne C. Rodloff

Institute for Medical Microbiology and Epidemiology of Infectious Diseases, University of Leipzig, Leipzig, Germany

Received 26 October 1998/Returned for modification 26 March 1999/Accepted 18 August 1999

The activity of the new fluoroquinolone gatifloxacin was compared with those of other quinolones and antimicrobial agents of other classes against 294 anaerobes by the broth microdilution technique. For all strains tested, gatifloxacin MICs at which 50 and 90% of the isolates were inhibited were 0.5 and 2 mg/liter, respectively, and were 3 to 4 dilution steps lower than, e.g., ciprofloxacin.

* Corresponding author. Mailing address: Institute for Medical Microbiology and Epidemiology of Infectious Diseases, University of Leipzig, Liebigstr. 24, D-04103 Leipzig, Germany. Phone: (0341) 97 15 200. Fax: (0341) 97 15 209. E-mail: schaur{at}medizin.uni-leipzig.de.

Antimicrobial Agents and Chemotherapy, November 1999, p. 2783-2786, Vol. 43, No. 11
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Tanaka, K., Mikamo, H., Nakao, K., Watanabe, K. (2006). In Vitro Antianaerobic Activity of DX-619, a New Des-Fluoro(6) Quinolone. Antimicrob. Agents Chemother. 50: 3908-3913 [Abstract] [Full Text]  
  • Liebetrau, A., Rodloff, A. C., Behra-Miellet, J., Dubreuil, L. (2003). In Vitro Activities of a New Des-Fluoro(6) Quinolone, Garenoxacin, against Clinical Anaerobic Bacteria. Antimicrob. Agents Chemother. 47: 3667-3671 [Abstract] [Full Text]  
  • Golan, Y., McDermott, L. A., Jacobus, N. V., Goldstein, E. J. C., Finegold, S., Harrell, L. J., Hecht, D. W., Jenkins, S. G., Pierson, C., Venezia, R., Rihs, J., Iannini, P., Gorbach, S. L., Snydman, D. R. (2003). Emergence of fluoroquinolone resistance among Bacteroides species. J Antimicrob Chemother 52: 208-213 [Abstract] [Full Text]  
  • Trampuz, A., Laifer, G., Wenk, M., Rajacic, Z., Zimmerli, W. (2002). Pharmacokinetics and Pharmacodynamics of Gatifloxacin against Streptococcus pneumoniae and Staphylococcus aureus in a Granulocyte-Rich Exudate. Antimicrob. Agents Chemother. 46: 3630-3633 [Abstract] [Full Text]  
  • Ackermann, G., Schaumann, R., Pless, B., Claros, M. C., Rodloff, A. C. (2000). In vitro activity of telithromycin (HMR 3647) and seven other antimicrobial agents against anaerobic bacteria. J Antimicrob Chemother 46: 115-119 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»